Real-world effectiveness of high-efficacy therapies in multiple sclerosis: a propensity score-matched cohort study

BackgroundEffectiveness classification of disease-modifying therapies (DMTs) in MS relies either on head-to-head trials or indirect comparisons of annualized relapse rates (ARR) across studies. Validating efficacy estimates in real-world settings is crucial, particularly as the discussion on the bro...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Jasmin Wich, Tatjana Beppler, Michelle Dreiling, André Scherag, Matthias Schwab, Florian Rakers
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2026-03-01
Serie:	Frontiers in Neurology
Soggetti:	disease-modifying therapies high-efficacy treatments multiple sclerosis propensity score matching real-world evidence
Accesso online:	https://www.frontiersin.org/articles/10.3389/fneur.2026.1773074/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!